-
StockWatch: Data, Big Name Investors Drive Prime Medicine Stock Surge
22 Sep 2025 16:33 GMT
… program assessing efzofitimod in pulmonary sarcoidosis failed the 268-patient Phase … forward for efzofitimod in pulmonary sarcoidosis. aTyr said the trial also … improvement in patients’ King’s Sarcoidosis Questionnaire (KSQ)-Lung score at …
-
The six-month-old baby in intensive care since birth who desperately needs a new heart
22 Sep 2025 14:56 GMT
… .
Helen had been diagnosed with sarcoidosis — a rare autoimmune condition that … Cullinane had been diagnosed with sarcoidosis - a rare autoimmune condition …
-
aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman
22 Sep 2025 15:08 GMT
… of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial …
-
Target, Treat, and Track: Superparamagnetic Iron Oxide Nanoparticles (SPION) Driven Theranostic Delivery of Antimicrobials to the Lungs
22 Sep 2025 13:16 GMT
… mechanisms of granuloma formation in sarcoidosis and tuberculosis. J Clin Investig …
-
'As soon as she was born it was clear something was wrong... it has blown our world apart'
22 Sep 2025 07:58 GMT
… .
Helen had been diagnosed with sarcoidosis - a rare autoimmune condition …
-
Mum knew there was 'something wrong' as soon as baby girl was born
22 Sep 2025 07:03 GMT
… .
Helen had been diagnosed with sarcoidosis - a rare autoimmune condition …
-
Parents of baby on heart transplant waiting list make desperate plea for donor
21 Sep 2025 23:25 GMT
… .
Helen had been diagnosed with sarcoidosis — a rare autoimmune condition that …
-
Tocilizumab for Non-Infectious Uveitis: A Systematic Review
20 Sep 2025 06:04 GMT
… idiopathic uveitis. Additional causes include sarcoidosis, Behçet’s disease (BD), and … with behçet’s syndrome and sarcoidosis: a single center study of …
-
Rx Rundown: Eli Lilly, Lila Sciences, Novartis and more
19 Sep 2025 12:44 GMT
… Phase 3 study of pulmonary sarcoidosis.
Exact Sciences debuted Cancerguard, a …
-
Top 3 Health Care Stocks That May Explode In September
19 Sep 2025 11:22 GMT
… study of efzofitimod in pulmonary sarcoidosis did not meet its primary …